secwatch.observer — SEC 8-K summary
======================================

Issuer:     Citius Pharmaceuticals, Inc. (CTXR)
CIK:        0001506251
Form:       8-K
Filed at:   2026-04-24T23:59:59+00:00
Accession:  0001213900-26-047599
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Pharma raises $5M via registered direct offering and private placement
-----------------------------------------------------------------------------

- Sold 5,076,143 shares/pre-funded warrants at $0.985 each; raised ~$5M gross, $4.5M net.
- Issued unregistered warrants to purchase 5,076,143 shares at $0.86, 5-year term, cashless exercise.
- Net proceeds to fund commercial launch of LYMPHIR and development of product candidates.
- 45-day lock-up on further equity issuance after closing; H.C. Wainwright acted as placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506251/000121390026047599/0001213900-26-047599-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506251/000121390026047599/ea0287620-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-047599

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer